A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months to one year has found that intermittent fasting may offer little to no significant benefit over standard dietary advice for weight loss in people with overweight or obesity. When compared to regular, calorie-restricted diet plans, intermittent fasting—which includes methods like time-restricted eating or alternate-day fasting—resulted in only a minimal difference in weight loss (an average of 0.33% greater loss) and showed no meaningful impact on quality of life or adverse events, though the evidence for the latter two outcomes is uncertain. The review also found that while fasting was somewhat more effective than doing nothing at all, it did not lead to clinically meaningful changes in most health outcomes. The authors conclude that physicians and patients should base the decision to try intermittent fasting on individual practicality and sustainability, rather than an expectation of superior results, noting that more long-term research is needed to understand its effects beyond 12 months. Source: https://www.cochranelibrary.com/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.